ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Mahmoud Yousef
Matched on ORCID iD 0009-0007-2550-4837; OpenAlex author ID A5034479353. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2024: 1 paper · 2025: 2 papers · 2026: 3 papers
Papers 6
- Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1093/oncolo/oyag423↗
- Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/pas.0000000000002470↗
- Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. Co-author DOI 10.1200/po-25-00703↗
- Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/oncolo/oyae182↗
- KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13045-025-01696-0↗
- Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41698-024-00505-0↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew H. G. Katz · 6 shared papers, 2024–2026 · strength 1.24
- Paper Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1097/pas.0000000000002470↗
- Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Dan Zhao · 5 shared papers, 2024–2026 · strength 1.05
- Paper Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1097/pas.0000000000002470↗
- Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Robert A. Wolff · 5 shared papers, 2024–2026 · strength 0.99
- Paper Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1097/pas.0000000000002470↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Anirban Maitra · 5 shared papers, 2024–2026 · strength 0.99
- Paper Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1097/pas.0000000000002470↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Rebecca Anne Snyder · 5 shared papers, 2024–2026 · strength 0.96
- Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Michael James Overman · 4 shared papers, 2024–2026 · strength 0.71
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Abdelrahman M.G. Yousef · 4 shared papers, 2024–2026 · strength 0.71
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Brandon George Smaglo · 4 shared papers, 2024–2026 · strength 0.71
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Shubham Pant · 4 shared papers, 2024–2026 · strength 0.71
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Huamin Wang · 3 shared papers, 2024–2026 · strength 0.63
- Paper Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1097/pas.0000000000002470↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. DOI 10.1038/s41698-024-00505-0↗
- Ching-Wei David Tzeng · 3 shared papers, 2025–2026 · strength 0.61
- Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Naruhiko Ikoma · 3 shared papers, 2025–2026 · strength 0.61
- Paper Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. DOI 10.1200/po-25-00703↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Ethan Bernard Ludmir · 3 shared papers, 2025–2026 · strength 0.55
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Eugene Jon Koay · 3 shared papers, 2025–2026 · strength 0.55
- Paper Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. DOI 10.1093/oncolo/oyae182↗
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Laura R. Prakash · 2 shared papers, 2026 · strength 0.53
- Jason A. Willis · 3 shared papers, 2024–2026 · strength 0.52
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Paper Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. DOI 10.1038/s41698-024-00505-0↗
- Saikat Chowdhury · 3 shared papers, 2024–2026 · strength 0.52
- Paper Site-Specific Outcomes and Genomics in Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1093/oncolo/oyag423↗
- Paper KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. DOI 10.1186/s13045-025-01696-0↗
- Paper Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. DOI 10.1038/s41698-024-00505-0↗
- Michael P. Kim · 2 shared papers, 2025–2026 · strength 0.42
- Haoqiang Ying · 2 shared papers, 2025–2026 · strength 0.36
- Ryan W. Huey · 2 shared papers, 2025–2026 · strength 0.36
- Hua Wang · 1 shared paper, 2026 · strength 0.28
- Shaimaa Elzamly · 1 shared paper, 2026 · strength 0.28
- Adriana Carolina Gamboa · 1 shared paper, 2026 · strength 0.25
- Jeffrey E. Lee · 1 shared paper, 2026 · strength 0.25
- James C. Yao · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.